Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: acadesine | 0.90 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 0 stopped | 1.00 |
| literature PubMed | 52 Parkinson's papers of 333 | 0.48 |
| pathways Reactome | 11 pathways; mostly lysosome and autophagy | 1.00 |
No case: the score is under the bar. Receipt 7656
Sealed predictions
- PRKAG2 in dopamine neurons, braak-0.04 (p 0.909) → -0.67 (p 0.048)receipt 7663
Swarm cases
receipt 7663: PRKAG2 in dopamine neurons, braak
- power
- full sample -0.50 (p 0.033, n 18), 95% CI -0.79 to -0.05. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.49 (p 0.037, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.69 (p 0.0014, n 18). not the mix.
- skeptic
- leave-one-out range -0.60 to -0.44, sign flips 0; without severely affected donors -0.50 (p 0.033, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PRKAG2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts